BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37264076)

  • 1. Clinicopathological and prognostic significance of LKB1 expression in gastric cancer: a systematic review and meta-analysis.
    Tan G; Liu B
    Sci Rep; 2023 Jun; 13(1):8937. PubMed ID: 37264076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between LKB1 expression and prognosis of patients with solid tumours: an updated systematic review and meta-analysis.
    Ren YH; Zhao FJ; Mo HY; Jia RR; Tang J; Zhao XH; Wei JL; Huo RR; Li QQ; You XM
    BMJ Open; 2019 Aug; 9(8):e027185. PubMed ID: 31383697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological and prognostic significance of the RUNX3 expression in gastric cancer: a systematic review and meta-analysis.
    Liu B; Han Y; Jiang L; Jiang D; Li W; Zhang T; Zu G; Zhang X
    Int J Surg; 2018 May; 53():122-128. PubMed ID: 29578091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of LKB1 is associated with epithelial-mesenchymal transition and led to an unfavorable prognosis in gastric cancer.
    Hu M; Zhao T; Liu J; Zou Z; Xu Q; Gong P; Guo H
    Hum Pathol; 2019 Jan; 83():133-139. PubMed ID: 30171989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prognostic Value of Decreased LKB1 in Solid Tumors: A Meta-Analysis.
    Xiao J; Zou Y; Chen X; Gao Y; Xie M; Lu X; Li W; He B; He S; You S; Chen Q
    PLoS One; 2016; 11(4):e0152674. PubMed ID: 27035914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer.
    Cao GD; Xu XY; Zhang JW; Chen B; Xiong MM
    PLoS One; 2016; 11(12):e0168085. PubMed ID: 28005970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased Expression of Tumor-suppressor Gene LKB1 Correlates with Poor Prognosis in Human Gastric Cancer.
    Sun J; Ling B; Xu X; Ma R; Li G; Cao X; Ling W; Yang Z; Hoffman RM; Lu J
    Anticancer Res; 2016 Mar; 36(3):869-75. PubMed ID: 26976973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparanase mRNA and Protein Expression Correlates with Clinicopathologic Features of Gastric Cancer Patients: a Meta- analysis.
    Li HL; Gu J; Wu JJ; Ma CL; Yang YL; Wang HP; Wang J; Wang Y; Chen C; Wu HY
    Asian Pac J Cancer Prev; 2015; 16(18):8653-8. PubMed ID: 26745132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.
    Li S; Wang Z; Huang J; Cheng S; Du H; Che G; Peng Y
    BMC Cancer; 2016 Nov; 16(1):877. PubMed ID: 27835987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological and prognostic significance of FoxM1 in gastric cancer: A meta-analysis.
    Jiang D; Jiang L; Liu B; Huang H; Li W; Zhang T; Zu G; Zhang X
    Int J Surg; 2017 Dec; 48():38-44. PubMed ID: 29017864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of relationship between PROX1 expression and clinicopathological parameters and prognosis in gastric cancer patients: a meta-analysis and TCGA analysis.
    Jia Z; Wang Y; Gao J; Zu G
    BMC Gastroenterol; 2022 Mar; 22(1):142. PubMed ID: 35346069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced expression of liver kinase B1 and Beclin1 is associated with the poor survival of patients with non-small cell lung cancer.
    Jiang L; Liang X; Liu M; Wang W; Ma J; Guo Q; Han L; Yang C; Nan K
    Oncol Rep; 2014 Nov; 32(5):1931-8. PubMed ID: 25175672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature.
    Lei YY; Huang JY; Zhao QR; Jiang N; Xu HM; Wang ZN; Li HQ; Zhang SB; Sun Z
    World J Surg Oncol; 2017 Mar; 15(1):68. PubMed ID: 28327158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of Copines-1 is associated with clinicopathological parameters and poor outcome in gastric cancer.
    Yang J; Wang Y; Ge R; Jia X; Ge C; Cen Y; Pan D
    J Clin Lab Anal; 2022 Nov; 36(11):. PubMed ID: 36310511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LKB1 expression and the prognosis of lung cancer: A meta-analysis.
    Lin C; Lin X; Lin K; Tan J; Wei C; Liu T
    Medicine (Baltimore); 2021 Nov; 100(46):e27841. PubMed ID: 34797317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between epithelial cell adhesion molecule (EpCAM) overexpression and gastric cancer patients: A systematic review and meta-analysis.
    Dai M; Yuan F; Fu C; Shen G; Hu S; Shen G
    PLoS One; 2017; 12(4):e0175357. PubMed ID: 28403178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LKB1 inhibits the proliferation of gastric cancer cells by suppressing the nuclear translocation of Yap and β-catenin.
    Ma LG; Bian SB; Cui JX; Xi HQ; Zhang KC; Qin HZ; Zhu XM; Chen L
    Int J Mol Med; 2016 Apr; 37(4):1039-48. PubMed ID: 26936013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor prognosis of phosphatase of regenerating liver 3 expression in gastric cancer: a meta-analysis.
    Hu L; Luo H; Wang W; Li H; He T
    PLoS One; 2013; 8(10):e76927. PubMed ID: 24204707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of lncRNA PVT1 for Patients with Gastric Cancer: A Meta-Analysis.
    Hao J; Yuan B; Gou Y; Ma J; Huang X
    Dis Markers; 2021; 2021():5595965. PubMed ID: 34900027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homeobox proteins are potential biomarkers and therapeutic targets in gastric cancer: a systematic review and meta-analysis.
    Jin X; Dai L; Ma Y; Wang J; Yan H; Jin Y; Zhu X; Liu Z
    BMC Cancer; 2020 Sep; 20(1):866. PubMed ID: 32907552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.